Priority Applications (2) Applications Claiming Priority (4) Publications (2) Family ID=8226822 Family Applications (1) Country Status (28) Families Citing this family (8) Family Cites Families (3) 1998 1998-05-20 KR KR10-1999-7010862A patent/KR100488038B1/en not_active Expired - Fee Related 1998-05-20 RS YUP-601/99A patent/RS49733B/en unknown 1998-05-20 DE DE69826653T patent/DE69826653T2/en not_active Expired - Lifetime 1998-05-20 PT PT98929345T patent/PT983300E/en unknown 1998-05-20 US US09/424,414 patent/US6288028B1/en not_active Expired - Lifetime 1998-05-20 SK SK1595-99A patent/SK159599A3/en unknown 1998-05-20 EP EP98929345A patent/EP0983300B1/en not_active Expired - Lifetime 1998-05-20 PL PL98336897A patent/PL193790B1/en unknown 1998-05-20 EA EA199901061A patent/EA002058B1/en not_active IP Right Cessation 1998-05-20 NZ NZ501323A patent/NZ501323A/en not_active IP Right Cessation 1998-05-20 CZ CZ0414299A patent/CZ299423B6/en not_active IP Right Cessation 1998-05-20 HU HU0002329A patent/HU227800B1/en not_active IP Right Cessation 1998-05-20 WO PCT/EP1998/002953 patent/WO1998052973A1/en not_active Ceased 1998-05-20 AT AT98929345T patent/ATE277948T1/en active 1998-05-20 JP JP54994898A patent/JP3492381B2/en not_active Expired - Fee Related 1998-05-20 CN CNB988053934A patent/CN1166683C/en not_active Expired - Fee Related 1998-05-20 TR TR1999/02866T patent/TR199902866T2/en unknown 1998-05-20 ES ES98929345T patent/ES2229507T3/en not_active Expired - Lifetime 1998-05-20 ID IDW991444A patent/ID23184A/en unknown 1998-05-20 UA UA99127002A patent/UA61955C2/en unknown 1998-05-20 CA CA002290739A patent/CA2290739C/en not_active Expired - Fee Related 1998-05-20 BR BRPI9809457-2A patent/BR9809457B1/en not_active IP Right Cessation 1998-05-20 IL IL13288498A patent/IL132884A0/en active IP Right Grant 1998-05-20 DK DK98929345T patent/DK0983300T3/en active 1998-05-20 AU AU79141/98A patent/AU731317B2/en not_active Ceased 1998-05-26 AR ARP980102425A patent/AR011478A1/en active IP Right Grant 1999 1999-11-11 IL IL132884A patent/IL132884A/en not_active IP Right Cessation 1999-11-19 BG BG103905A patent/BG64023B1/en unknown 1999-11-19 NO NO19995692A patent/NO321126B1/en not_active IP Right Cessation
30 , 61429 doi: in press (2016)
In artificially induced hyperglycemia, the levels of IL-6, TNF and IL-18 in human plasma increased sharply, which may be related to the mechanism of oxidative stress: Under the condition of hyperglycemia, the uptake of glucose by endothelial cells increases, resulting in excessive production of ROS in mitochondria, which causes oxidative damage and activates the inflammatory signaling cascade in endothelial cells, releasing a large number of inflammatory cytokines into the blood (Esposito et al
It was formed on November 16, 2020, through the merger of Mylan and Upjohn, a legacy division of Pfizer
This design resulted in seven partially overlapping but distinct analytical cohorts (trial 1 (the primary trial) for the composite SUD, and trials 2-7 for alcohol, cannabis, cocaine, nicotine, opioid, and other SUD), aligning the at risk population with the outcome for each trial
